comparemela.com

Latest Breaking News On - Nova stock down - Page 1 : comparemela.com

Insider Selling: LivaNova PLC (NASDAQ:LIVN) Director Sells 56,623 Shares of Stock

LivaNova PLC (NASDAQ:LIVN – Get Free Report) Director Daniel Jeffrey Moore sold 56,623 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $60.11, for a total transaction of $3,403,608.53. Following the transaction, the director now directly owns 27,534 shares in the company, valued at […]

Switzerland
Arizona
United-states
Swiss
Robertw-baird
Daniel-jeffrey-moore
Jump-financial
Vanguard-personalized-indexing-management
Swiss-national-bank
Charles-schwab-investment-management-inc
Needham-company
Barclays

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Down 0.7 % MNOV opened at $1.34 on Thursday. The firm has a market cap of $65.73 million, a P/E ratio of -7.88 and […]

United-states
Zurich
Züsz
Switzerland
Bank-julius-baer-co
Ltd-zurich
Exchange-commission
Medicinova-inc
Nasdaq
Free-report
Nova-stock-down

LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of "Hold" from Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN – Get Free Report) have received a consensus rating of “Hold” from the five research firms that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price target […]

Robertw-baird
Lazard-asset-management
Livanova-company-profile
Barclays
Acadian-asset-management
Headlands-technologies
Vanguard-personalized-indexing-management
Needham-company
Get-free-report
Nova-stock-down
Asset-management

Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $64.40

LivaNova PLC (NASDAQ:LIVN – Get Free Report) has earned a consensus rating of “Hold” from the five analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokers […]

Robertw-baird
Headlands-technologies
Needham-company
Barclays
Livanova-company-profile
Us-bancorp
Lazard-asset-management
Get-free-report
Asset-management
Mahoney-asset-management
Nova-stock-down

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Down 2.6 % Shares of MNOV stock opened at $1.47 on Wednesday. The stock has a fifty day moving average of $1.61 and a 200 […]

United-states
Medicinova-inc
Renaissance-technologies
Jpmorgan-chase-co
Medicinova-company-profile
Dimensional-fund-advisors
Geode-capital-management
Free-report
Nova-stock-down
Get-free-report
Capital-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.